• 3070 Bristol Pike, Suite 112, Bensalem, PA 19020

  • Call Us: (215) 638-4847 |

    Fax: (215) 638-4867

Pharming Group N.V. (NASDAQ: PHAR)

Case Details

Join The Class Action

This investigation is for anyone who acquired securities in Pharming Group N.V. (NASDAQ: PHAR) prior to July 30, 2026.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by failing to timely inform investors that the Company oversupplied pharmacies with RUCONEST.

On July 30, 2026, the Company reported second quarter earnings, including revenue of $90.2 million, reflecting a 3.2% year over year decline. Further, the Company reported a 10% revenue decline for RUCONEST. The Company stated, among other things, that “the year-over-year decline reflected…temporary inventory normalization.” The Company also cut its full year revenue guidance approximately $30 million at the midpoint to $375 to $395 million and stated “[a]t the midpoint of our guidance range, RUCONEST U.S. revenue is expected to decline approximately 3% for the full year.” On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Pharming Group N.V. (NASDAQ: PHAR) prior to July 30, 2026 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.